Shanghai Junshi Biosciences Co., Ltd. (1877.HK) Stock Price, News & Chart

	1877.HK	2162.HK	688382.SS	2696.HK	688062.SS	SMZ1.F
Market cap	16.34B	20.67B	8.38B	27.67B	10.13B	11.09B
P/E (TTM)	—	23.8	—	28.8	—	31.2
Forward P/E	66.7	206.8	-43.8	28.2	-21.6	—
Price/book	2.4	4.4	6.6	5.2	14.1	2.6
Dividend yield	—	—	—	—	—	2.90%
1-year change	−39.19%	+8.65%	−48.70%	−19.71%	−51.34%	−23.60%
Today	+1.53%	+2.48%	+4.33%	+1.78%	+5.29%	+1.45%

Market cap

16.34B

20.67B

8.38B

27.67B

10.13B

11.09B

P/E (TTM)

—

23.8

—

28.8

—

31.2

Forward P/E

66.7

206.8

-43.8

28.2

-21.6

—

Price/book

2.4

4.4

6.6

5.2

14.1

2.6

Dividend yield

—

2.90%

1-year change

−39.19%

+8.65%

−48.70%

−19.71%

−51.34%

−23.60%

Today

+1.53%

+2.48%

+4.33%

+1.78%

+5.29%

+1.45%

Company	Mkt cap	Price	Today
Keymed Biosciences Inc.2162.HK · Biotechnology	20.67B	70.150	+2.48%
InventisBio Co., Limited688382.SS · Biotechnology	8.38B	14.45	+4.33%
Shanghai Henlius Biotech, Inc.2696.HK · Biotechnology	27.67B	50.750	+1.78%
Mabwell (Shanghai) Bioscience Co., Ltd.688062.SS · Biotechnology	10.13B	22.67	+5.29%
Sino Biopharmaceutical LimitedSMZ1.F · Biotechnology	11.09B	0.6235	+1.45%
Suzhou Zelgen Biopharmaceuticals Co., Ltd.688266.SS · Biotechnology	24.15B	91.25	+0.12%
InnoCare Pharma Limited9969.HK · Biotechnology	21.56B	12.200	+1.33%
Sinocelltech Group Limited688520.SS · Biotechnology	15.35B	32.63	+1.02%

Company	Mkt cap	Price	Today
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.2315.HK · Beijing, China	19.07B	42.980	+2.09%
Innovent Biologics, Inc.6IB.F · Suzhou, China	17.27B	9.91	+3.42%
Zealand Pharma A/SZEAL.CO · Søborg, Denmark	16.04B	241.80	+2.03%
Medigen Vaccine Biologics Corporation6547.TWO · Zhubei, Taiwan	15.63B	47.55	−2.16%
Ascendis Pharma A/SASND · Hellerup, Denmark	16.97B	257.93	+3.10%
Jazz Pharmaceuticals plcJAZZ · Dublin, Ireland	15.06B	234.66	+2.14%
Titan Biotech LimitedTITANBIO.BO · New Delhi, India	17.07B	330.50	+2.40%
CanBas Co., Ltd.4575.T · Numazu, Japan	13.16B	668.00	−5.65%

Company	Mkt cap	Price	Today
Shanghai Conant Optical Co., Ltd.2276.HK · Medical Instruments & Supplies	17.87B	36.980	+3.76%
ScinoPharm Taiwan, Ltd.1789.TW · Drug Manufacturers - Specialty & Generic	15.38B	19.45	−2.26%
NGL Fine-Chem LimitedNGLFINE.BO · Drug Manufacturers - General	17.71B	2,866.75	+6.37%
Topchoice Medical Co., Inc.600763.SS · Medical Care Facilities	16.72B	37.61	+0.43%
Micro-Tech (Nanjing) Co.,Ltd688029.SS · Medical Instruments & Supplies	16.60B	88.35	+3.94%
Tarsons Products LimitedTARSONS.NS · Medical Instruments & Supplies	16.94B	318.40	+2.35%
YungShin Global Holding Corporation3705.TW · Drug Manufacturers - Specialty & Generic	15.88B	59.60	0.00%
Sartorius AktiengesellschaftSRT.F · Medical Instruments & Supplies	15.64B	226.50	−0.66%

Company	Mkt cap	Price	Today
Semiconductor Manufacturing International Corporation0981.HK · Shanghai, China	406.71B	47.500	+2.28%
Bank of Communications Co., Ltd.C4C.F · Shanghai, China	85.24B	0.9646	−0.62%
WuXi AppTec Co., Ltd.2359.HK · Shanghai, China	620.33B	204.400	+3.34%
Shanghai Pudong Development Bank Co., Ltd.600000.SS · Shanghai, China	328.73B	9.87	−2.18%
East Money Information Co.,Ltd.300059.SZ · Shanghai, China	300.31B	18.98	−1.15%
China Pacific Insurance (Group) Co., Ltd.2601.HK · Shanghai, China	271.29B	28.200	+1.73%
Guotai Haitong Securities Co., Ltd.2611.HK · Shanghai, China	236.82B	13.470	+1.05%
China CSSC Holdings Limited600150.SS · Shanghai, China	266.26B	35.38	−0.39%

Company	Mkt cap	Price	Today
Innovent Biologics, Inc.1801.HK · life sciences	154.42B	88.550	+4.12%
Bio-Techne CorporationTE1.F · life sciences	9.93B	63.22	−0.97%
Nxera Pharma Co., Ltd.4565.T · life sciences	158.60B	1,729.00	+13.75%
SK Biopharmaceuticals Co., Ltd.326030.KS · life sciences	7.10T	90,600.00	+12.27%
Celltrion, Inc.068270.KS · life sciences	49.02T	215,000.00	+7.50%
Chongqing Lummy Pharmaceutical Co., Ltd.300006.SZ · life sciences	10.81B	10.24	+7.45%
Santen Pharmaceutical Co., Ltd.4536.T · life sciences	604.65B	1,882.00	+4.79%
Eli Lilly and CompanyLLY.F · life sciences	1.14T	1,275.40	+0.81%

Company	Mkt cap	Price	Today
Akeso, Inc.9926.HK · Correlation 0.71	80.92B	87.850	+6.48%
InnoCare Pharma Limited9969.HK · Correlation 0.71	21.56B	12.200	+1.33%
Mabwell (Shanghai) Bioscience Co., Ltd.688062.SS · Correlation 0.66	10.13B	22.67	+5.29%
Keymed Biosciences Inc.2162.HK · Correlation 0.66	20.67B	70.150	+2.48%
Innovent Biologics, Inc.1801.HK · Correlation 0.64	154.42B	88.550	+4.12%
InventisBio Co., Limited688382.SS · Correlation 0.64	8.38B	14.45	+4.33%
Sinocelltech Group Limited688520.SS · Correlation 0.62	15.35B	32.63	+1.02%
Innovent Biologics, Inc.6IB.F · Correlation 0.60	17.27B	9.91	+3.42%

Company	Mkt cap	Price	Today
INNOVENT BIO1801.HK	154.42B	88.550	+4.12%
BEONE MEDICINES6160.HK	367.68B	248.600	+7.34%
AKESO9926.HK	80.92B	87.850	+6.48%
INNOCARE9969.HK	21.56B	12.200	+1.33%
CSTONE PHARMA-B2616.HK	8.98B	5.635	+4.16%

MarketScreener·6d ago

Shanghai Junshi Biosciences Doses First Patient in Phase 3 Trial for Lymphoma Drug

Shanghai Junshi Biosciences dosed its first patient in the phase 3 clinical trial of its self-developed JS203 drug, according to a Saturday filing with the Shanghai bourse. The company is... Shanghai Junshi Biosciences Co., Ltd. Shanghai…

CRS CDE MOS AZN

MarketScreener·6d agoPositive

Shanghai Junshi Biosciences' Urothelial Cancer Drug Application Accepted in China

China's National Medical Products Administration accepted Shanghai Junshi Biosciences' new drug application for its toripalimab subcutaneous injection, according to a Thursday disclosure to the... Shanghai Junshi Biosciences Co., Ltd.…

AZN JHPCY

markets.businessinsider.com·Oct 24·2 outlets

SDIC Securities Remains a Buy on Shanghai Junshi Biosciences Co., Ltd. Class H (1877)

SDIC Securities analyst maintained a Buy rating on Shanghai Junshi Biosciences Co., Ltd. Class H yesterday and set a price target of HK$26.84. ... SDIC Securities analyst maintained a Buy rating on Shanghai Junshi Biosciences Co., Ltd.…

SXTC BIYA DEO RGC

Shanghai Junshi Biosciences Co., Ltd Enters Licensing Collaboration with Fosun Wanbang Pharma Group on Roconkibart (Il-17A)

Shanghai Junshi Biosciences Co., Ltd. announced that the company has recently entered into a license agreement with Fosun Wanbang Pharma Group. The two parties will cooperate on the development,... Shanghai Junshi Biosciences Co., Ltd…

NVS JHPCY AZN

Markets Daily·Oct 11Negative

Shanghai Junshi Biosciences Co., Ltd. (OTCMKTS:SHJBF) Stock Short Interest Drops 80.0%

Posted by Kim Johansen on Oct 11th, 2026 Shanghai Junshi Biosciences Co., Ltd. (OTCMKTS:SHJBF – Get Free Report) saw a significant decline in short interest in the month of September. As of September 30th, there was short interest totaling…

INDI OXBR HHGSY

MarketScreener·Oct 23Positive

Shanghai Junshi Biosciences Co., Ltd. Appoints Chen Liang as Independent Non-Executive Director and Announces Change in Composition of Board Committees, Effective June 26, 2026

The board of directors of Shanghai Junshi Biosciences Co., Ltd. announced the election of Mr. Chen Liang as an Independent Non-executive Director was approved at the AGM held on 26 June 2026. The... The board of directors of Shanghai…

AGM LEGN NVS AZN

MarketScreener·Oct 23

Shanghai Junshi Biosciences Return to Profit in H1

Shanghai Junshi Biosciences booked an attributable profit of 25.5 million yuan in the first half of 2026, returning from a loss of 413.4 million yuan a year prior, a Wednesday Hong Kong bourse... Shanghai Junshi Biosciences Co., Ltd.…

MarketScreener·Oct 23

Shanghai Junshi Biosciences Co., Ltd.: Relative Strength Chart - Stock Hong Kong S.E.

Compare Shanghai Junshi Biosciences Co., Ltd. with the company of your choice via a Relative Strength chart. Real-time 1877 price, Hong Kong S.E. stock exchange Relative Strength Chart Shanghai Junshi Biosciences Co., Ltd. All financial…

TSLA DEO RGC RBB

MarketScreener·Oct 23Positive

Shanghai Junshi Biosciences Co., Ltd Announces Completion Of First Patient Dosing In Phase 3 Clinical Trial Of JS203 In Combination With Chemotherapy For Treatment Of Diffuse Large B-Cell Lymphoma

Shanghai Junshi Biosciences Co., Ltd. announced that the first patient dosing has been completed in a randomized, open-label, multicenter phase 3 clinical study of the company?s product, a recombinant ... Shanghai Junshi Biosciences Co.,…

Days on the list

30 d

1 yr

Best

Trending

—

Install

Shanghai Junshi Biosciences Co., Ltd.

Key statistics

Against its peers

Latest news